Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off 
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns 
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility 
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock 
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient 
Oil Prices Slide on US-Iran Talks, Dollar Strength and Profit-Taking Pressure 
South Korea’s Weak Won Struggles as Retail Investors Pour Money Into U.S. Stocks 
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals 
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal 
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal 
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns 
Australia’s December Trade Surplus Expands but Falls Short of Expectations 
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination 
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm 
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off 
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices 
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility 
Starboard Value’s Investment in Kenvue Inc.
Activist hedge fund Starboard Value has taken a "sizeable" stake in Kenvue Inc., according to *The Wall Street Journal*. While the exact percentage of the investment is undisclosed, Starboard is pushing for changes aimed at boosting Kenvue's stock price. Kenvue, which was spun off from Johnson & Johnson in 2023, has seen its stock underperform both its industry peers and the broader market since its debut.
Kenvue’s Strong Consumer Brands
Kenvue boasts several well-known consumer brands, such as Tylenol, Listerine, and Band-Aid. Despite its strong portfolio, Kenvue's stock performance has been relatively muted in 2024, while the S&P 500 has surged by 24%. Starboard believes that these valuable brands are not yet reflected in the company’s current valuation.
Starboard’s Broader Strategy
This is not the first major move by Starboard Value. The hedge fund, led by CEO Jeff Smith, recently acquired a $1 billion stake in pharmaceutical giant Pfizer and has been involved in advocating for changes at tech companies like Salesforce, Autodesk, and Match Group.
